Data Insights
Q2 2024 update: artificial intelligence related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 10% rise in new job postings related to artificial intelligence in Q2 2024 compared...
Q2 2024 update: corporate governance related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 9% rise in new job postings related to corporate governance in Q2 2024 compared...
Q2 2024 update: cybersecurity related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 7% drop in new job postings related to cybersecurity in Q2 2024 compared with...
Who’s hiring who? Social Responsibility hiring activity decreased by 38% in the pharmaceutical industry in Q1 2023
The global pharmaceutical industry experienced a 38% drop in new job postings related to social responsibility in Q1 2023 compared...
Q3 2023 update: cell & gene therapy related hiring actvity in the pharma industry
The global pharmaceutical industry experienced an 11% drop in new job postings related to cell & gene therapy in Q3...
Artificial Intelligence hiring activity dropped in the pharma industry in Q3 2023
The global pharmaceutical industry experienced a 39% drop in new job postings related to artificial intelligence in Q3 2023 compared...
Q3 2023 update: cloud related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 30% drop in new job postings related to cloud in Q3 2023 compared with...
Corporate Governance hiring activity dropped in the pharma industry in Q3 2023
The global pharmaceutical industry experienced a 39% drop in new job postings related to corporate governance in Q3 2023 compared...
Q3 2023 update: cybersecurity related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 37% drop in new job postings related to cybersecurity in Q3 2023 compared with...
Q3 2023 update: immuno-oncology related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in...
How big data M&A performed in the pharmaceutical industry in Q2 2023
Analysis of the key themes driving M&A activity reveals that big data accounted for 3 pharmaceutical deals announced in Q2...
Q3 2023 update: environmental sustainability related hiring actvity in the pharma industry
The global pharmaceutical industry experienced an 11% drop in new job postings related to environmental sustainability in Q3 2023 compared...
Q3 2023 update: social responsibility related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 13% drop in new job postings related to social responsibility in Q3 2023 compared...
Environmental sustainability related patent filings decreased in the pharmaceutical industry in Q2 2023
The global pharmaceutical industry experienced a 10% decline in the number of environmental sustainability-related patent applications in Q2 2023 compared...
Q3 2023 update: virtual care related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 3 pharmaceutical deals announced in Q3...
Q3 2023 update: orphan designated drugs related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that orphan designated drugs accounted for 34 pharmaceutical deals announced in...
Q3 2023 update: mentions of big data in pharmaceutical industry filings
The global pharmaceutical industry experienced a 25% drop in company filings mentions of big data in Q3 2023 compared with...
How did the pharmaceutical industry treat blockchain in Q3 2023 filings?
The global pharmaceutical industry experienced a 58% drop in company filings mentions of blockchain in Q3 2023 compared with the...
How did the pharmaceutical industry treat future of work in Q3 2023 filings?
The global pharmaceutical industry experienced a 51% drop in company filings mentions of future of work in Q3 2023 compared...
How did the pharmaceutical industry treat orphan designated drugs in Q3 2023 filings?
The global pharmaceutical industry experienced a 1% drop in company filings mentions of orphan designated drugs in Q3 2023 compared...